LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia.

Leiva, Andrea / Fuenzalida, Bárbara / Westermeier, Francisco / Toledo, Fernando / Salomón, Carlos / Gutiérrez, Jaime / Sanhueza, Carlos / Pardo, Fabián / Sobrevia, Luis

Oxidative medicine and cellular longevity

2015  Volume 2015, Page(s) 5346327

Abstract: ... leading to maternal supraphysiological hypercholesterolemia (MSPH). This condition results in endothelial ... link between MSPH and BH4 in causing human fetoplacental vascular endothelial dysfunction, which may be ... for endothelial NO synthase (eNOS), is reduced in nonpregnant women who have hypercholesterolemia, which favors ...

Abstract Maternal physiological hypercholesterolemia occurs during pregnancy, ensuring normal fetal development. In some cases, the maternal plasma cholesterol level increases to above this physiological range, leading to maternal supraphysiological hypercholesterolemia (MSPH). This condition results in endothelial dysfunction and atherosclerosis in the fetal and placental vasculature. The fetal and placental endothelial dysfunction is related to alterations in the L-arginine/nitric oxide (NO) pathway and the arginase/urea pathway and results in reduced NO production. The level of tetrahydrobiopterin (BH4), a cofactor for endothelial NO synthase (eNOS), is reduced in nonpregnant women who have hypercholesterolemia, which favors the generation of the superoxide anion rather than NO (from eNOS), causing endothelial dysfunction. However, it is unknown whether MSPH is associated with changes in the level or metabolism of BH4; as a result, eNOS function is not well understood. This review summarizes the available information on the potential link between MSPH and BH4 in causing human fetoplacental vascular endothelial dysfunction, which may be crucial for understanding the deleterious effects of MSPH on fetal growth and development.
MeSH term(s) Animals ; Arginine/metabolism ; Biopterins/analogs & derivatives ; Biopterins/metabolism ; Borohydrides/metabolism ; Cholesterol/blood ; Endothelium, Vascular/metabolism ; Female ; Humans ; Hypercholesterolemia/metabolism ; Hypercholesterolemia/pathology ; Nitric Oxide/metabolism ; Nitric Oxide Synthase Type III/metabolism ; Pregnancy
Chemical Substances Borohydrides ; Biopterins ; Nitric Oxide (31C4KY9ESH) ; Arginine (94ZLA3W45F) ; Cholesterol (97C5T2UQ7J) ; Nitric Oxide Synthase Type III (EC 1.14.13.39) ; sapropterin (EGX657432I)
Language English
Publishing date 2015-11-30
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID 2455981-7
ISSN 1942-0994 ; 1942-0994
ISSN (online) 1942-0994
ISSN 1942-0994
DOI 10.1155/2016/5346327
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top